NOUGUES MAXIMO F
Chief Financial Officer
NOUGUES MAXIMO F has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jul 9, 2026.
On the most recent filing, NOUGUES MAXIMO F is listed as Chief Financial Officer at PUMA BIOTECHNOLOGY, INC. Inside the rolling window, NOUGUES MAXIMO F reported no open-market purchases and 3 open-market sales totaling $142K in PBYI. The largest disclosed transaction in the window is a sale of 9,386 PBYI shares on Jul 6, 2026, worth $78K.
Companies traded
Other insiders at PBYI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$142K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has NOUGUES MAXIMO F made?
NOUGUES MAXIMO F has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does NOUGUES MAXIMO F trade?
NOUGUES MAXIMO F has filed SEC Form 4 disclosures for 1 company, including PBYI.
When was NOUGUES MAXIMO F's most recent SEC Form 4 filing?
NOUGUES MAXIMO F's most recent SEC Form 4 filing on Tracefour is dated Jul 9, 2026.
What is NOUGUES MAXIMO F's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, NOUGUES MAXIMO F is listed as Chief Financial Officer.
What is NOUGUES MAXIMO F's total buy and sell value in the current window?
Inside the rolling retention window, NOUGUES MAXIMO F bought $0 and sold $142K based on SEC Form 4 filings.
What was NOUGUES MAXIMO F's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 9,386 PBYI shares on 2026-07-06, worth $78K, per SEC Form 4 filings.